Recent summary of changes to the LAM
The tables below show a summary of changes to the list of approved medicines (LAM) since it was last published. The LAM is published monthly or more frequently if required.
Additions
| Faricimab intraocular injection 6mg/0.05mL, vial |
| Phenol injection 5% in Oil 5mL |
Amendments
| Ruxolitinib tablet 5mg, 10mg |
| Ruxolitinib tablet 15mg, 20mg |
| Sotrovimab injection 500mg/8mL |
| Casirivimab + imdevimab (Ronapreve®) injection 120 mg/mL + 120 mg/mL |
| Remdesivir injection 100mg/20mL |
| Baricitinib tablet 2mg, 4mg |
| Molnupiravir capsule 200mg |
| Nirmatrelvir + ritonavir tablets 150mg + 100mg (Paxlovid®) |
| Tocilizumab injection 80mg/4mL, 200mg/10mL, 400mg/20mL |
| Etanercept injection 50mg (pre-filled syringe, auto-injector) |
Deletions
| Fiasp (insulin aspart – fast acting) injection 100 units/mL, 3mL pen device and 10mL vial |
| Hydromorphone modified release (MR) tablets 4mg, 8mg, 16mg, 32mg, 64mg |
Last updated: 5 June 2023
